Pfizer’s oral drug to treat coronavirus at the first sign of illness could be available by the end of 2021, CEO Albert Bourla said.
The company is now testing two drugs _ one taken by mouth, and the other through the intervein injection.
Pfizer’s oral drug to treat coronavirus at the first sign of illness could be available by the end of 2021, CEO Albert Bourla said.
The company is now testing two drugs _ one taken by mouth, and the other through the intervein injection.